Member Info for bigAl67

Hi Magsy,
Thanks for your reply.
The GDR valuation I have posted is based on potential Sales and Profit, not current Sales and Profit.
NCYT Mcap is the here and now, and stands at a multiple of 4 times GDR's Mcap of £51 mil.
I have not looked into NCYT potential Sales and Profit numbers, but with COVID Test Sales projected to increase considerably, in line with huge demand, I would expect NCYT Sales and subsequent Profits to increase immensely too ! - along with a much higher Mcap than its current £208 mil !
Have you seen the VOX interview that PP posted earlier today, both NCYT and GDR were mentioned most favourably, well worth a listen.
Cheers. I hope this helps.

Thanks Ihavenoclue,
I believe we will all be rewarded in time, we all just need to keep the faith !
Cheers Budd - pardon the DB pun !

Hi PP,
Thanks for the link, very informative.
It certainly shows that 50k Test sales, in the USA, is not over optimistic !.

Hi Grim,
I totally agree.
I have just posted a potential GDR Mcap valuation in reply to Magsy's question, and I based GDR's Tests in the USA, selling at £10/Test, and used DB's quote of 60% profit margin.
My potential valuation does not even take into consideration COVID Test sales outside of the USA, or potential sales/profit from our other Quality Products. !
Great times, heading our way IMO

Hi Magsy,
I believe that GDR Mcap is potentially worth £300 mil, based on projected Sales and Profit.
I expect GDR to sell 50,000 RT-PCR Test units/day at £10 per Test = £500,000 per day revenue at 60% profit margin = £300,000 per day profit.
Working on a 5 day week = 5 x £300,000 = £1,500,000 profit per week.
£1,500,000 x 50 wks per year = £75,000,000 profit per year.
Using a standard multiple of 4 for valuation = 4 x £75,000,000 = Mcap of £300,000,000
Mcap of £300,000,000 divided by 52,000,000 shares = a potential SP of £5.77p
Hope this helps ?

Hi Jay,
Yes me too, just maybe they are in agreement, now that the positive evidence is stacking up for a Big SP increase !

Hi Livinhope,
300 mCAP DIVIDED BY qty 52 MIL shares = £5.77p per share

Hi Starresnstoff,
Totally agree, if all the ducks line up the way it's looking/set to plan our SP could end up being worth 300m, and every GDR Share holder will be rewarded for their patience, no matter what price they paid for their shareholding ! IMO
I am Holding for the longer term !
Also agree, the Mcap range is likely to be some where between 150 to 180m, some time soon//over the coming months IMO

Hi PP,
Good question:- Does this exemption apply to GDR due to collab with BC, or still excluded as we are selling manufactured test kit to GC (even if embedded in an automated lab process)?
Will be interesting to know the answer to this question ? Hopefully, this will become clear over the coming days !

Good morning/afternoon Safy,
Great debate last night/early hours, looking Good for GDR's future SP.
Interesting times ahead, for sure !

Hi Invest4,
Yes agreed, : it sounds like they’ll introduce it initially at one of the labs for Aegis Sciences Corporation or Sonic Healthcare USA and then roll out across their other testing sites to get to the 10.

Hi Gloria,
$6.5 mil just for the set up to handle up to an additional 4 million tests a month? Who will pay for the tests then?

I do not believe that HHS would spend $6.5 mil to Lab's for increasing their throughput facilities to increase Testing capabilities by 100,000 Tests per day, without considering where the money will come from to pay for these additional Tests?
Likewise, I also do not believe that Labs would agree to expanding their facilities to increase their throughput by 10,000 Tests per Lab, without being convinced/guaranteed payment for these additional Tests, is available ? (even though the cost of expansion is being financed by the HHS).

Hi Dave77,
Yes agreed, :- 10 sites at 10k per site per day, that will be over 24 hours, 100,000 a day. Let’s be conservative and say GDR gets £5 a test, we would all be happy at that. £3.5mill a week is inline with previous comments from DB. However we still have other possible routes to other markets to increase that figure.

Hi Safy,

Is this the RNS statement you are referring too:
We are both working to have the ongoing validation completed in approximately 6 weeks, with initial introduction in the USA at an already identified clinical laboratory."

I read this as they have identified a clinical Lab for initial introduction ?
However, the need is for an increase of 10,000 tests/day at each of 10 Labs = an additional 100,000 Tests per day at potentially £10/Test = £1 mil per day !
I really must sleep now,
Cheers Bud.

Hi Safy,

Agreed - and 100,000 Tests at potentially £10 per Test = a value of £1mil per day.

I will read it again in the morning, after a nights sleep !

Hi Safy,

As I read it, it does say 10 sites with an increase of 10,000 Tests per day from each site, and then goes on to say = an increase of 100,000 Tests per day !

Hi Safy,
I may be wrong, as kit is late:-

Beckman Coulter Life Sciences will provide equipment that will enable laboratories to optimize their workflow, thereby increasing SARS-CoV-2 testing by up to 10,000 tests each day at 10 separate sites totaling an increase of 100,000 per day across the country.
An increase of 100,000/day at £10/Test = £1 mil/day ?

Hi Safy,
Beckman Coulter Life Sciences will provide equipment that will enable laboratories to optimize their workflow, thereby increasing SARS-CoV-2 testing by up to 10,000 tests each day at 10 separate sites totaling an increase of 100,000 per day across the country.
An increase100,000

Still trying to get my head around this !

One shift of 10 hrs at 10,000/hr =100,000 Tets/day, supplying BC across 10 sites, at £10 per Test = £1 mil/day potentially.
Still leaves another 10 hr shift to supply India and say Africa with a further 100,000 Tests/day at £10/ Test, for a further £1 mil/day potentially ???£££ = a potential £730 mil/ yr (in a 7 day working week), I am just running into dream world now, but feels Good !